Neuropsychological, neuropsychiatric, and quality‐of‐life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study

INTRODUCTION: We report the effects of plasma exchange (PE) with albumin replacement on neuropsychological, neuropsychiatric, and quality‐of‐life (QoL) outcomes in mild‐to‐moderate Alzheimer's disease (AD) patients in a phase 2b/3 trial (Alzheimer's Management by Albumin Replacement [AMBAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Boada, Mercè, López, Oscar L., Olazarán, Javier, Núñez, Laura, Pfeffer, Michael, Puente, Orlando, Piñol‐Ripoll, Gerard, Gámez, José E., Anaya, Fernando, Kiprov, Dobri, Alegret, Montserrat, Grifols, Carlota, Barceló, Miquel, Bozzo, Jordi, Szczepiorkowski, Zbigniew M., Páez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540900/
https://www.ncbi.nlm.nih.gov/pubmed/34726348
http://dx.doi.org/10.1002/alz.12477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540900/
https://www.ncbi.nlm.nih.gov/pubmed/34726348
http://dx.doi.org/10.1002/alz.12477

Ejemplares similares